Autism DNA hub opens

  • Published 2016 in Nature Biotechnology

Abstract

“This is the kind of news CIRM has yearned for in recent years: significant private cash that gives CIRM-funded projects a push to become actual products and to return value to the state,” writes journalist Alex Lash about Stanford spin-out Forty Seven (named after the cell surface marker CD47). The project, out of Irving Weissman’s lab, received $30… (More)
DOI: 10.1038/nbt0416-364

Topics

  • Presentations referencing similar topics